Company profile
NeutroGen Therapeutics
We are pioneering neutrophil transfusion therapies.
- Industry
- Biotechnology Research
- Employees
- 5
- Headquarters
- Berlin
- Founded
- 2024
- Office locations
- 1
NeutroGen Therapeutics company summary
NeutroGen Therapeutics is a company in the Biotechnology Research industry, headquartered in Berlin, founded in 2024. On LinkedIn the company has around 5 employees.
What technology does NeutroGen Therapeutics use?
No technologies detected yet. Warmrank rechecks company websites on a rolling basis.
About NeutroGen Therapeutics
NeutroGen Therapeutics is developing a ready-to-use cell-transfusion product designed to support cancer patients when chemotherapy leaves them temporarily without enough functional neutrophils. Our first focus is severe febrile neutropenia in acute leukemia — a high-risk phase where infections can become life-threatening and standard care with antibiotics and G-CSF is often not enough. By generating cryopreservable, allogeneic neutrophils ex vivo, we aim to provide rapid innate immune support when patients need it most.
Where is NeutroGen Therapeutics located?
NeutroGen Therapeutics lists 1 location.
Compare companies similar to NeutroGen Therapeutics
More companies in Biotechnology Research.
| Company | Industry | Employees | Founded | Headquarters |
|---|---|---|---|---|
NeutroGen Therapeutics neutrogen-therapeutics.com | Biotechnology Research | 5 | 2024 | Berlin |
 Thermo Fisher Scientific thermofisher.com | Biotechnology Research | 100,779 | - | Waltham, MA |
 Amgen amgen.com | Biotechnology Research | 41,028 | 1980 | Thousand Oaks, CA |
 Biogen biogen.com | Biotechnology Research | 7,742 | - | Cambridge, MA |
 Biocon biocon.com | Biotechnology Research | 11,902 | - | Bangalore, Karnataka |
| Biotechnology Research | 28,679 | - | Bethesda, MD | |
 Genentech gene.com | Biotechnology Research | 18,296 | 1976 | South San Francisco, California |
 Eurofins eurofins.com | Biotechnology Research | 24,928 | - | Luxembourg, Luxembourg |
 Gilead Sciences gilead.com | Biotechnology Research | 14,743 | - | Foster City, CA |
 Syneos Health syneoshealth.com | Biotechnology Research | 23,772 | - | Morrisville, NC |
 Moderna modernatx.com | Biotechnology Research | 6,238 | 2010 | Cambridge, Massachusetts |
Frequently asked questions about NeutroGen Therapeutics
What does NeutroGen Therapeutics do?
NeutroGen Therapeutics is developing a ready-to-use cell-transfusion product designed to support cancer patients when chemotherapy leaves them temporarily without enough functional neutrophils. Our first focus is severe febrile neutropenia in acute leukemia — a high-risk phase where infections can become life-threatening and standard care with antibiotics and G-CSF is often not enough. By generating cryopreservable, allogeneic neutrophils ex vivo, we aim to provide rapid innate immune support when patients need it most.
How many employees does NeutroGen Therapeutics have?
NeutroGen Therapeutics has around 5 employees on LinkedIn.
Where is NeutroGen Therapeutics headquartered?
NeutroGen Therapeutics is headquartered in Berlin.
When was NeutroGen Therapeutics founded?
NeutroGen Therapeutics was founded in 2024.
Build a lead list from companies like NeutroGen Therapeutics
Describe your ICP or import a CSV. Warmrank finds matching companies, enriches contacts with verified emails, and tracks every lead.